
Denmark · Biotechnology startup
AFYX Therapeutics is a clinical stage biopharmaceutical company
Funding reportedLast round: Debt financing
Follow AFYX Therapeutics and see its new rounds in your feed.Start following
Funding, as reported
From AFYX Therapeutics's own website: 8 on the team.
Add your raise, your deck and your story, and put AFYX Therapeutics in front of investors. Or tell us what we have wrong.